SYMLIN ® (pramlintide acetate) injection

First Page		Document Content
Biology Anti-diabetic drugs Peptide hormones Recombinant proteins Blood tests Pramlintide Sulfonylurea Diabetes management Insulin therapy Diabetes Endocrine system Medicine		SYMLIN ® (pramlintide acetate) injection Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 979,98 KB Share Document on Facebook

	North Shore Hematology / Oncology Associates, P.C. Conquering Cancer… Close to Home™ The following information is mandatory and of g DocID: 1pCOH - View Document
	Camillo Ricordi Director, Diabetes Research Institute and Cell transplant Program, University of Miami Synopsis of area of interest: Development of cell therapy technologies and tolerance induction strategies for DocID: 1kLKg - View Document
	Practical aspects of large register studies: Multiple states and multiple timescales: The diabetes and cancer study. Bendix Carstensen Senior Statistician, Steno Diabetes Center, Denmark DocID: 1gtMJ - View Document
	Emerging Treatments and Technologies O R I G I N A L A R T I C L E Implementation of a Safe and Effective DocID: 1ggrg - View Document
	Artificial pancreas device systems in development for the closed-loop control of type 1 diabetes DocID: 1fBJy - View Document